

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | behavioral response to nicotine (GO:0035095) | 5.70551230 |
| 2 | indole-containing compound catabolic process (GO:0042436) | 5.17862311 |
| 3 | indolalkylamine catabolic process (GO:0046218) | 5.17862311 |
| 4 | tryptophan catabolic process (GO:0006569) | 5.17862311 |
| 5 | L-phenylalanine catabolic process (GO:0006559) | 5.14061335 |
| 6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.14061335 |
| 7 | aromatic amino acid family catabolic process (GO:0009074) | 5.05534217 |
| 8 | tryptophan metabolic process (GO:0006568) | 5.02357425 |
| 9 | L-phenylalanine metabolic process (GO:0006558) | 4.41487922 |
| 10 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.41487922 |
| 11 | cellular biogenic amine catabolic process (GO:0042402) | 4.33325378 |
| 12 | amine catabolic process (GO:0009310) | 4.33325378 |
| 13 | L-fucose catabolic process (GO:0042355) | 4.30034940 |
| 14 | fucose catabolic process (GO:0019317) | 4.30034940 |
| 15 | L-fucose metabolic process (GO:0042354) | 4.30034940 |
| 16 | kynurenine metabolic process (GO:0070189) | 4.17790008 |
| 17 | bile acid biosynthetic process (GO:0006699) | 4.07789647 |
| 18 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.97417113 |
| 19 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.93192701 |
| 20 | urea cycle (GO:0000050) | 3.89152786 |
| 21 | urea metabolic process (GO:0019627) | 3.89152786 |
| 22 | complement activation, alternative pathway (GO:0006957) | 3.87126568 |
| 23 | response to pheromone (GO:0019236) | 3.84115934 |
| 24 | cellular ketone body metabolic process (GO:0046950) | 3.82639668 |
| 25 | regulation of protein activation cascade (GO:2000257) | 3.81253650 |
| 26 | indolalkylamine metabolic process (GO:0006586) | 3.79804434 |
| 27 | negative regulation of telomere maintenance (GO:0032205) | 3.79410028 |
| 28 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 3.78903509 |
| 29 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 3.73015349 |
| 30 | negative regulation of lipase activity (GO:0060192) | 3.72667903 |
| 31 | alpha-linolenic acid metabolic process (GO:0036109) | 3.66819880 |
| 32 | glyoxylate metabolic process (GO:0046487) | 3.59884679 |
| 33 | phospholipid homeostasis (GO:0055091) | 3.59845047 |
| 34 | regulation of complement activation (GO:0030449) | 3.57651265 |
| 35 | bile acid metabolic process (GO:0008206) | 3.52600092 |
| 36 | high-density lipoprotein particle remodeling (GO:0034375) | 3.48526038 |
| 37 | nitrogen cycle metabolic process (GO:0071941) | 3.42729352 |
| 38 | ketone body metabolic process (GO:1902224) | 3.42391012 |
| 39 | epithelial cilium movement (GO:0003351) | 3.40189876 |
| 40 | amino-acid betaine metabolic process (GO:0006577) | 3.35473117 |
| 41 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.32555113 |
| 42 | neural tube formation (GO:0001841) | 3.31696033 |
| 43 | kidney morphogenesis (GO:0060993) | 3.31643959 |
| 44 | triglyceride homeostasis (GO:0070328) | 3.31611831 |
| 45 | acylglycerol homeostasis (GO:0055090) | 3.31611831 |
| 46 | reverse cholesterol transport (GO:0043691) | 3.31492841 |
| 47 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.30616284 |
| 48 | aromatic amino acid family metabolic process (GO:0009072) | 3.29189699 |
| 49 | negative regulation of protein activation cascade (GO:2000258) | 3.28976575 |
| 50 | detection of light stimulus involved in visual perception (GO:0050908) | 3.27683201 |
| 51 | detection of light stimulus involved in sensory perception (GO:0050962) | 3.27683201 |
| 52 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.25724943 |
| 53 | regulation of fibrinolysis (GO:0051917) | 3.25581656 |
| 54 | phospholipid efflux (GO:0033700) | 3.23426372 |
| 55 | DNA deamination (GO:0045006) | 3.15503782 |
| 56 | homocysteine metabolic process (GO:0050667) | 3.13327477 |
| 57 | NAD biosynthetic process (GO:0009435) | 3.12176410 |
| 58 | tyrosine metabolic process (GO:0006570) | 3.12036949 |
| 59 | indole-containing compound metabolic process (GO:0042430) | 3.11242773 |
| 60 | regulation of bile acid biosynthetic process (GO:0070857) | 3.11137801 |
| 61 | histone H3-K4 trimethylation (GO:0080182) | 3.09943895 |
| 62 | cilium or flagellum-dependent cell motility (GO:0001539) | 3.09829240 |
| 63 | gamma-aminobutyric acid transport (GO:0015812) | 3.08812067 |
| 64 | protein carboxylation (GO:0018214) | 3.08263130 |
| 65 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.08263130 |
| 66 | regulation of triglyceride catabolic process (GO:0010896) | 3.07868410 |
| 67 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.07523399 |
| 68 | NADH dehydrogenase complex assembly (GO:0010257) | 3.07523399 |
| 69 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.07523399 |
| 70 | plasma lipoprotein particle assembly (GO:0034377) | 3.07413847 |
| 71 | sulfur amino acid catabolic process (GO:0000098) | 3.07236926 |
| 72 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 3.03714717 |
| 73 | regulation of translation, ncRNA-mediated (GO:0045974) | 3.03714717 |
| 74 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 3.03714717 |
| 75 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.02402383 |
| 76 | plasma lipoprotein particle remodeling (GO:0034369) | 3.01822507 |
| 77 | protein-lipid complex remodeling (GO:0034368) | 3.01822507 |
| 78 | macromolecular complex remodeling (GO:0034367) | 3.01822507 |
| 79 | nephron epithelium morphogenesis (GO:0072088) | 3.00265200 |
| 80 | nephron tubule morphogenesis (GO:0072078) | 3.00265200 |
| 81 | cilium movement (GO:0003341) | 2.97731889 |
| 82 | cholesterol efflux (GO:0033344) | 2.94323795 |
| 83 | neuronal action potential (GO:0019228) | 2.92798663 |
| 84 | imidazole-containing compound metabolic process (GO:0052803) | 2.92182056 |
| 85 | regulation of telomere maintenance (GO:0032204) | 2.91912280 |
| 86 | protein complex biogenesis (GO:0070271) | 2.91909780 |
| 87 | alpha-amino acid catabolic process (GO:1901606) | 2.90961581 |
| 88 | nonmotile primary cilium assembly (GO:0035058) | 2.90854446 |
| 89 | bile acid and bile salt transport (GO:0015721) | 2.90310613 |
| 90 | opsonization (GO:0008228) | 2.89171259 |
| 91 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.87424565 |
| 92 | protein activation cascade (GO:0072376) | 2.86995614 |
| 93 | cellular glucuronidation (GO:0052695) | 2.85222280 |
| 94 | axoneme assembly (GO:0035082) | 2.84992934 |
| 95 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 2.84837681 |
| 96 | serine family amino acid catabolic process (GO:0009071) | 2.84653025 |
| 97 | sulfation (GO:0051923) | 2.84236097 |
| 98 | blood coagulation, intrinsic pathway (GO:0007597) | 2.84156613 |
| 99 | primary amino compound metabolic process (GO:1901160) | 2.84043338 |
| 100 | nucleobase catabolic process (GO:0046113) | 2.82032524 |
| 101 | negative regulation of complement activation (GO:0045916) | 2.81812397 |
| 102 | rRNA catabolic process (GO:0016075) | 2.81716835 |
| 103 | fatty acid beta-oxidation (GO:0006635) | 2.81259328 |
| 104 | regulation of glucokinase activity (GO:0033131) | 2.81230573 |
| 105 | regulation of hexokinase activity (GO:1903299) | 2.81230573 |
| 106 | coenzyme catabolic process (GO:0009109) | 2.80044811 |
| 107 | platelet dense granule organization (GO:0060155) | 2.79650219 |
| 108 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.78988884 |
| 109 | negative regulation of fibrinolysis (GO:0051918) | 2.78964447 |
| 110 | short-chain fatty acid metabolic process (GO:0046459) | 2.78458259 |
| 111 | reciprocal meiotic recombination (GO:0007131) | 2.78204862 |
| 112 | reciprocal DNA recombination (GO:0035825) | 2.78204862 |
| 113 | complement activation, classical pathway (GO:0006958) | 2.77750446 |
| 114 | behavioral response to ethanol (GO:0048149) | 2.77651695 |
| 115 | low-density lipoprotein particle remodeling (GO:0034374) | 2.77471332 |
| 116 | piRNA metabolic process (GO:0034587) | 2.77441417 |
| 117 | complement activation (GO:0006956) | 2.77336983 |
| 118 | carnitine metabolic process (GO:0009437) | 2.76840588 |
| 119 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.75656418 |
| 120 | plasma lipoprotein particle organization (GO:0071827) | 2.75532559 |
| 121 | positive regulation of respiratory burst (GO:0060267) | 2.74439781 |
| 122 | regulation of phospholipase A2 activity (GO:0032429) | 2.74379998 |
| 123 | reflex (GO:0060004) | 2.74227964 |
| 124 | cornea development in camera-type eye (GO:0061303) | 2.73538352 |
| 125 | regulation of action potential (GO:0098900) | 2.73348445 |
| 126 | cilium morphogenesis (GO:0060271) | 2.73332527 |
| 127 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.73054381 |
| 128 | protein-lipid complex assembly (GO:0065005) | 2.72975810 |
| 129 | regulation of posttranscriptional gene silencing (GO:0060147) | 2.70697739 |
| 130 | regulation of gene silencing by miRNA (GO:0060964) | 2.70697739 |
| 131 | regulation of gene silencing by RNA (GO:0060966) | 2.70697739 |
| 132 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 2.70577451 |
| 133 | cilium organization (GO:0044782) | 2.68559233 |
| 134 | protein polyglutamylation (GO:0018095) | 2.67863255 |
| 135 | valine metabolic process (GO:0006573) | 2.67566381 |
| 136 | fatty acid oxidation (GO:0019395) | 2.66593919 |
| 137 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 2.66305456 |
| 138 | pyridine nucleotide biosynthetic process (GO:0019363) | 2.66305456 |
| 139 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.65682411 |
| 140 | lipid oxidation (GO:0034440) | 2.63949625 |
| 141 | plasma lipoprotein particle clearance (GO:0034381) | 2.63805604 |
| 142 | respiratory chain complex IV assembly (GO:0008535) | 2.63432267 |
| 143 | nucleotide transmembrane transport (GO:1901679) | 2.63326894 |
| 144 | protein K11-linked deubiquitination (GO:0035871) | 2.62994263 |
| 145 | inner ear receptor stereocilium organization (GO:0060122) | 2.62945526 |
| 146 | regulation of cholesterol esterification (GO:0010872) | 2.62589880 |
| 147 | serotonin metabolic process (GO:0042428) | 2.62535496 |
| 148 | urate metabolic process (GO:0046415) | 2.61435105 |
| 149 | cilium assembly (GO:0042384) | 2.60767933 |
| 150 | regulation of mesoderm development (GO:2000380) | 2.59044069 |
| 151 | ubiquinone biosynthetic process (GO:0006744) | 2.59041807 |
| 152 | fatty acid catabolic process (GO:0009062) | 2.58555846 |
| 153 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 2.58491187 |
| 154 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.58140422 |
| 155 | linoleic acid metabolic process (GO:0043651) | 2.58019148 |
| 156 | regulation of hippo signaling (GO:0035330) | 2.57650755 |
| 157 | protein-lipid complex subunit organization (GO:0071825) | 2.57593137 |
| 158 | replication fork processing (GO:0031297) | 2.55317340 |
| 159 | purine nucleotide transport (GO:0015865) | 2.54854024 |
| 160 | somite rostral/caudal axis specification (GO:0032525) | 2.54603470 |
| 161 | androgen biosynthetic process (GO:0006702) | 2.54485599 |
| 162 | cysteine metabolic process (GO:0006534) | 2.53934807 |
| 163 | benzene-containing compound metabolic process (GO:0042537) | 2.53643842 |
| 164 | negative regulation of transcription regulatory region DNA binding (GO:2000678) | 2.53641835 |
| 165 | cellular amino acid catabolic process (GO:0009063) | 2.53551644 |
| 166 | negative regulation of DNA-dependent DNA replication (GO:2000104) | 2.51878011 |
| 167 | monocarboxylic acid catabolic process (GO:0072329) | 2.51636592 |
| 168 | cAMP catabolic process (GO:0006198) | 2.51410265 |
| 169 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 2.50998942 |
| 170 | purine ribonucleotide transport (GO:0015868) | 2.50306353 |
| 171 | ethanol oxidation (GO:0006069) | 2.50106143 |
| 172 | rhodopsin mediated signaling pathway (GO:0016056) | 2.49394258 |
| 173 | negative regulation of mast cell activation (GO:0033004) | 2.49244332 |
| 174 | alanine transport (GO:0032328) | 2.48320082 |
| 175 | auditory receptor cell stereocilium organization (GO:0060088) | 2.47523797 |
| 176 | ubiquinone metabolic process (GO:0006743) | 2.47355879 |
| 177 | spinal cord motor neuron differentiation (GO:0021522) | 2.46973066 |
| 178 | proline transport (GO:0015824) | 2.46830070 |
| 179 | protein-cofactor linkage (GO:0018065) | 2.46569093 |
| 180 | recombinational repair (GO:0000725) | 2.45626668 |
| 181 | hindbrain development (GO:0030902) | 2.45193854 |
| 182 | androgen metabolic process (GO:0008209) | 2.45159557 |
| 183 | protein localization to cilium (GO:0061512) | 2.44575695 |
| 184 | lipoprotein metabolic process (GO:0042157) | 2.44177209 |
| 185 | regulation of humoral immune response (GO:0002920) | 2.44138135 |
| 186 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.44073820 |
| 187 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 2.42556697 |
| 188 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.42482411 |
| 189 | double-strand break repair via homologous recombination (GO:0000724) | 2.41918675 |
| 190 | dopamine transport (GO:0015872) | 2.41575230 |
| 191 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.40918856 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ZNF274_21170338_ChIP-Seq_K562_Hela | 4.18382894 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.02627126 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.83777953 |
| 4 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.80843251 |
| 5 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.28855474 |
| 6 | VDR_22108803_ChIP-Seq_LS180_Human | 3.28827940 |
| 7 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.84362424 |
| 8 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.76433470 |
| 9 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.61450942 |
| 10 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.53181637 |
| 11 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.32751572 |
| 12 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.23742841 |
| 13 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.17760642 |
| 14 | GATA1_22025678_ChIP-Seq_K562_Human | 2.12754758 |
| 15 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.08758851 |
| 16 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.03859170 |
| 17 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.02999978 |
| 18 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.95492255 |
| 19 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.90951086 |
| 20 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.86942238 |
| 21 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.84451127 |
| 22 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.84426848 |
| 23 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.83346026 |
| 24 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.83008752 |
| 25 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.82918596 |
| 26 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.81282438 |
| 27 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.79845066 |
| 28 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.79499322 |
| 29 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.78128416 |
| 30 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.77644716 |
| 31 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.75825082 |
| 32 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.75360797 |
| 33 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.71908037 |
| 34 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.70889867 |
| 35 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.69328821 |
| 36 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.68813016 |
| 37 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.67725894 |
| 38 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.65456789 |
| 39 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.64331735 |
| 40 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.62389229 |
| 41 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.60559684 |
| 42 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.59307519 |
| 43 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.58984784 |
| 44 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.58708436 |
| 45 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.57874371 |
| 46 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.56974966 |
| 47 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.51072016 |
| 48 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.48512597 |
| 49 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.47954796 |
| 50 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.47912577 |
| 51 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.47912577 |
| 52 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.47447987 |
| 53 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.47381700 |
| 54 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.47052164 |
| 55 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.46420770 |
| 56 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.45253186 |
| 57 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.45253186 |
| 58 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.44857974 |
| 59 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.42810279 |
| 60 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.42180468 |
| 61 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.40250431 |
| 62 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.39848495 |
| 63 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.37730629 |
| 64 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.37239962 |
| 65 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.37130401 |
| 66 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.36930935 |
| 67 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.36096356 |
| 68 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.35575804 |
| 69 | * CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.34909701 |
| 70 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.33146694 |
| 71 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.31831595 |
| 72 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.31596354 |
| 73 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.31526238 |
| 74 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.31379843 |
| 75 | * IRF1_19129219_ChIP-ChIP_H3396_Human | 1.31210787 |
| 76 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.31091162 |
| 77 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.30756936 |
| 78 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.29941651 |
| 79 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.29764760 |
| 80 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.28956570 |
| 81 | P300_19829295_ChIP-Seq_ESCs_Human | 1.28328917 |
| 82 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.27856753 |
| 83 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.26710622 |
| 84 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.26710622 |
| 85 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.26685474 |
| 86 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.26652967 |
| 87 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.26314134 |
| 88 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.25733807 |
| 89 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.25728847 |
| 90 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.25728847 |
| 91 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.25433976 |
| 92 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.24549620 |
| 93 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.24021622 |
| 94 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.23976848 |
| 95 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.23834215 |
| 96 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.22349535 |
| 97 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.19956008 |
| 98 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.19936736 |
| 99 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.18968506 |
| 100 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.18928208 |
| 101 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.18337974 |
| 102 | TP53_16413492_ChIP-PET_HCT116_Human | 1.17243699 |
| 103 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.16226993 |
| 104 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.15041160 |
| 105 | PU1_27457419_Chip-Seq_LIVER_Mouse | 1.14674166 |
| 106 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.14604184 |
| 107 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.14556750 |
| 108 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.14142601 |
| 109 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.13729357 |
| 110 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.11857864 |
| 111 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.11564297 |
| 112 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.11348235 |
| 113 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.10932042 |
| 114 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.10648343 |
| 115 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.09847151 |
| 116 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 1.09404409 |
| 117 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.09322615 |
| 118 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 1.08953851 |
| 119 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.08778776 |
| 120 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.08498106 |
| 121 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.08486990 |
| 122 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.07612915 |
| 123 | STAT3_23295773_ChIP-Seq_U87_Human | 1.07135245 |
| 124 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 1.06958001 |
| 125 | AR_20517297_ChIP-Seq_VCAP_Human | 1.06116793 |
| 126 | * FUS_26573619_Chip-Seq_HEK293_Human | 1.04820808 |
| 127 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 1.04306695 |
| 128 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.03388070 |
| 129 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.03180781 |
| 130 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.03177876 |
| 131 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.03014673 |
| 132 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 1.02952423 |
| 133 | NCOR_22424771_ChIP-Seq_293T_Human | 1.02089863 |
| 134 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.02014301 |
| 135 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.01991355 |
| 136 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.01561697 |
| 137 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.00303147 |
| 138 | HOXB7_26014856_ChIP-Seq_BT474_Human | 1.00106290 |
| 139 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.99984746 |
| 140 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.99422450 |
| 141 | KDM2B_26808549_Chip-Seq_REH_Human | 0.98303423 |
| 142 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.97967596 |
| 143 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.97078658 |
| 144 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.96964156 |
| 145 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.96964156 |
| 146 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.96505277 |
| 147 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.96286182 |
| 148 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.95800065 |
| 149 | TCF4_23295773_ChIP-Seq_U87_Human | 0.95248964 |
| 150 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.95246738 |
| 151 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.95052076 |
| 152 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.94877332 |
| 153 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.94578382 |
| 154 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.94380191 |
| 155 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.94313480 |
| 156 | * EWS_26573619_Chip-Seq_HEK293_Human | 0.94243511 |
| 157 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.94228677 |
| 158 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.93689902 |
| 159 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.93568184 |
| 160 | JUN_21703547_ChIP-Seq_K562_Human | 0.92677641 |
| 161 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.92384426 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 5.75641912 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 5.66724097 |
| 3 | MP0005365_abnormal_bile_salt | 5.20992318 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 4.56986241 |
| 5 | MP0003252_abnormal_bile_duct | 3.69565134 |
| 6 | MP0000566_synostosis | 3.23220074 |
| 7 | MP0008875_abnormal_xenobiotic_pharmacok | 2.93888960 |
| 8 | MP0008877_abnormal_DNA_methylation | 2.80010279 |
| 9 | MP0005451_abnormal_body_composition | 2.69306849 |
| 10 | MP0009697_abnormal_copulation | 2.42039802 |
| 11 | MP0004381_abnormal_hair_follicle | 2.42025850 |
| 12 | MP0010329_abnormal_lipoprotein_level | 2.41007789 |
| 13 | MP0005551_abnormal_eye_electrophysiolog | 2.38296405 |
| 14 | MP0005670_abnormal_white_adipose | 2.33385157 |
| 15 | MP0003195_calcinosis | 2.33056977 |
| 16 | MP0000569_abnormal_digit_pigmentation | 2.23916487 |
| 17 | MP0001666_abnormal_nutrient_absorption | 2.15654913 |
| 18 | MP0003787_abnormal_imprinting | 2.15334523 |
| 19 | MP0003868_abnormal_feces_composition | 2.14585279 |
| 20 | MP0001968_abnormal_touch/_nociception | 2.12007276 |
| 21 | MP0004133_heterotaxia | 2.04766151 |
| 22 | MP0009745_abnormal_behavioral_response | 2.00614672 |
| 23 | MP0009046_muscle_twitch | 1.95441110 |
| 24 | MP0010368_abnormal_lymphatic_system | 1.94255612 |
| 25 | MP0002138_abnormal_hepatobiliary_system | 1.91166877 |
| 26 | MP0002653_abnormal_ependyma_morphology | 1.90985334 |
| 27 | MP0004142_abnormal_muscle_tone | 1.87716355 |
| 28 | MP0004043_abnormal_pH_regulation | 1.84574726 |
| 29 | MP0008872_abnormal_physiological_respon | 1.84205336 |
| 30 | MP0003880_abnormal_central_pattern | 1.82201805 |
| 31 | MP0006072_abnormal_retinal_apoptosis | 1.81166174 |
| 32 | MP0002254_reproductive_system_inflammat | 1.79303429 |
| 33 | MP0003646_muscle_fatigue | 1.78085133 |
| 34 | MP0002837_dystrophic_cardiac_calcinosis | 1.77141151 |
| 35 | MP0005408_hypopigmentation | 1.76334202 |
| 36 | MP0001485_abnormal_pinna_reflex | 1.73342081 |
| 37 | MP0004885_abnormal_endolymph | 1.73017542 |
| 38 | MP0005647_abnormal_sex_gland | 1.70638478 |
| 39 | MP0002736_abnormal_nociception_after | 1.70075236 |
| 40 | MP0005253_abnormal_eye_physiology | 1.68965365 |
| 41 | MP0002272_abnormal_nervous_system | 1.65281750 |
| 42 | MP0001986_abnormal_taste_sensitivity | 1.59636468 |
| 43 | MP0003890_abnormal_embryonic-extraembry | 1.58503235 |
| 44 | MP0002928_abnormal_bile_duct | 1.57935013 |
| 45 | MP0006276_abnormal_autonomic_nervous | 1.56922017 |
| 46 | MP0002118_abnormal_lipid_homeostasis | 1.56568739 |
| 47 | MP0000631_abnormal_neuroendocrine_gland | 1.55172773 |
| 48 | MP0003950_abnormal_plasma_membrane | 1.51328642 |
| 49 | MP0000609_abnormal_liver_physiology | 1.49344106 |
| 50 | MP0001486_abnormal_startle_reflex | 1.46822147 |
| 51 | MP0009764_decreased_sensitivity_to | 1.46205705 |
| 52 | MP0002876_abnormal_thyroid_physiology | 1.45198852 |
| 53 | MP0002938_white_spotting | 1.44891746 |
| 54 | MP0002572_abnormal_emotion/affect_behav | 1.44883638 |
| 55 | MP0001501_abnormal_sleep_pattern | 1.43906148 |
| 56 | MP0005332_abnormal_amino_acid | 1.43850503 |
| 57 | MP0002557_abnormal_social/conspecific_i | 1.42499816 |
| 58 | MP0004019_abnormal_vitamin_homeostasis | 1.41208527 |
| 59 | MP0004145_abnormal_muscle_electrophysio | 1.38709132 |
| 60 | MP0002064_seizures | 1.37174739 |
| 61 | MP0005409_darkened_coat_color | 1.36515045 |
| 62 | MP0000383_abnormal_hair_follicle | 1.33294528 |
| 63 | MP0002163_abnormal_gland_morphology | 1.28485631 |
| 64 | MP0000579_abnormal_nail_morphology | 1.28282747 |
| 65 | MP0001764_abnormal_homeostasis | 1.28018108 |
| 66 | MP0003136_yellow_coat_color | 1.27569082 |
| 67 | MP0005083_abnormal_biliary_tract | 1.27400478 |
| 68 | MP0004742_abnormal_vestibular_system | 1.26273938 |
| 69 | MP0005220_abnormal_exocrine_pancreas | 1.26218892 |
| 70 | MP0002067_abnormal_sensory_capabilities | 1.25112122 |
| 71 | MP0002160_abnormal_reproductive_system | 1.23591937 |
| 72 | MP0000427_abnormal_hair_cycle | 1.21858560 |
| 73 | MP0002735_abnormal_chemical_nociception | 1.19653540 |
| 74 | MP0000778_abnormal_nervous_system | 1.18740858 |
| 75 | MP0002733_abnormal_thermal_nociception | 1.18045785 |
| 76 | MP0001970_abnormal_pain_threshold | 1.17789946 |
| 77 | MP0001835_abnormal_antigen_presentation | 1.16211424 |
| 78 | MP0002063_abnormal_learning/memory/cond | 1.15487751 |
| 79 | MP0001529_abnormal_vocalization | 1.15203263 |
| 80 | MP0005195_abnormal_posterior_eye | 1.14833025 |
| 81 | MP0009763_increased_sensitivity_to | 1.14770905 |
| 82 | MP0003635_abnormal_synaptic_transmissio | 1.14344043 |
| 83 | MP0001984_abnormal_olfaction | 1.13925591 |
| 84 | MP0005387_immune_system_phenotype | 1.12957094 |
| 85 | MP0001790_abnormal_immune_system | 1.12957094 |
| 86 | MP0005389_reproductive_system_phenotype | 1.12505845 |
| 87 | MP0005386_behavior/neurological_phenoty | 1.11042422 |
| 88 | MP0004924_abnormal_behavior | 1.11042422 |
| 89 | MP0003878_abnormal_ear_physiology | 1.09173835 |
| 90 | MP0005377_hearing/vestibular/ear_phenot | 1.09173835 |
| 91 | MP0002971_abnormal_brown_adipose | 1.08438552 |
| 92 | MP0009384_cardiac_valve_regurgitation | 1.06968784 |
| 93 | MP0001346_abnormal_lacrimal_gland | 1.06770809 |
| 94 | MP0003119_abnormal_digestive_system | 1.06462622 |
| 95 | MP0000685_abnormal_immune_system | 1.05864210 |
| 96 | MP0003121_genomic_imprinting | 1.04623989 |
| 97 | MP0001919_abnormal_reproductive_system | 1.02284071 |
| 98 | MP0003283_abnormal_digestive_organ | 1.00965889 |
| 99 | MP0006292_abnormal_olfactory_placode | 1.00554923 |
| 100 | MP0005646_abnormal_pituitary_gland | 1.00338057 |
| 101 | MP0005075_abnormal_melanosome_morpholog | 0.99966668 |
| 102 | MP0001905_abnormal_dopamine_level | 0.97505164 |
| 103 | MP0002752_abnormal_somatic_nervous | 0.97478166 |
| 104 | MP0003191_abnormal_cellular_cholesterol | 0.97387966 |
| 105 | MP0003137_abnormal_impulse_conducting | 0.96409615 |
| 106 | MP0005334_abnormal_fat_pad | 0.95910899 |
| 107 | MP0003718_maternal_effect | 0.94672646 |
| 108 | MP0000026_abnormal_inner_ear | 0.93654034 |
| 109 | MP0005174_abnormal_tail_pigmentation | 0.91978005 |
| 110 | MP0003011_delayed_dark_adaptation | 0.91723640 |
| 111 | MP0002734_abnormal_mechanical_nocicepti | 0.91617196 |
| 112 | MP0001293_anophthalmia | 0.91286032 |
| 113 | MP0004215_abnormal_myocardial_fiber | 0.90449677 |
| 114 | MP0003122_maternal_imprinting | 0.90260011 |
| 115 | MP0009765_abnormal_xenobiotic_induced | 0.90158802 |
| 116 | MP0010386_abnormal_urinary_bladder | 0.89058526 |
| 117 | MP0001270_distended_abdomen | 0.88767510 |
| 118 | MP0008995_early_reproductive_senescence | 0.88392883 |
| 119 | MP0003937_abnormal_limbs/digits/tail_de | 0.88385869 |
| 120 | MP0008058_abnormal_DNA_repair | 0.88372915 |
| 121 | MP0008961_abnormal_basal_metabolism | 0.88246462 |
| 122 | MP0002234_abnormal_pharynx_morphology | 0.87516708 |
| 123 | MP0002095_abnormal_skin_pigmentation | 0.87264408 |
| 124 | MP0002184_abnormal_innervation | 0.86746475 |
| 125 | MP0001324_abnormal_eye_pigmentation | 0.85952762 |
| 126 | MP0003698_abnormal_male_reproductive | 0.85944941 |
| 127 | MP0005379_endocrine/exocrine_gland_phen | 0.85857786 |
| 128 | MP0005319_abnormal_enzyme/_coenzyme | 0.84165645 |
| 129 | MP0002751_abnormal_autonomic_nervous | 0.84160951 |
| 130 | MP0003806_abnormal_nucleotide_metabolis | 0.84146135 |
| 131 | MP0001879_abnormal_lymphatic_vessel | 0.83788123 |
| 132 | MP0000647_abnormal_sebaceous_gland | 0.83239185 |
| 133 | MP0000767_abnormal_smooth_muscle | 0.83123733 |
| 134 | MP0005410_abnormal_fertilization | 0.82492430 |
| 135 | MP0005187_abnormal_penis_morphology | 0.82204345 |
| 136 | MP0004147_increased_porphyrin_level | 0.82041294 |
| 137 | MP0005423_abnormal_somatic_nervous | 0.80975109 |
| 138 | MP0001502_abnormal_circadian_rhythm | 0.80405282 |
| 139 | MP0002229_neurodegeneration | 0.80047676 |
| 140 | MP0000230_abnormal_systemic_arterial | 0.79913480 |
| 141 | MP0005167_abnormal_blood-brain_barrier | 0.79788994 |
| 142 | MP0005084_abnormal_gallbladder_morpholo | 0.78881544 |
| 143 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.78736903 |
| 144 | MP0002168_other_aberrant_phenotype | 0.74986547 |
| 145 | MP0005464_abnormal_platelet_physiology | 0.74898906 |
| 146 | MP0002419_abnormal_innate_immunity | 0.74277979 |
| 147 | MP0000015_abnormal_ear_pigmentation | 0.74135170 |
| 148 | MP0000372_irregular_coat_pigmentation | 0.74033736 |
| 149 | MP0003724_increased_susceptibility_to | 0.72197774 |
| 150 | MP0002277_abnormal_respiratory_mucosa | 0.72130473 |
| 151 | MP0008469_abnormal_protein_level | 0.70174034 |
| 152 | MP0010678_abnormal_skin_adnexa | 0.69534890 |
| 153 | MP0002396_abnormal_hematopoietic_system | 0.68752275 |
| 154 | MP0009840_abnormal_foam_cell | 0.68291311 |
| 155 | MP0001853_heart_inflammation | 0.68132350 |
| 156 | MP0002638_abnormal_pupillary_reflex | 0.68028276 |
| 157 | MP0005666_abnormal_adipose_tissue | 0.67285209 |
| 158 | MP0002098_abnormal_vibrissa_morphology | 0.66775676 |
| 159 | MP0003690_abnormal_glial_cell | 0.66549096 |
| 160 | MP0000613_abnormal_salivary_gland | 0.66405302 |
| 161 | MP0000538_abnormal_urinary_bladder | 0.66281443 |
| 162 | MP0003656_abnormal_erythrocyte_physiolo | 0.64404778 |
| 163 | MP0009785_altered_susceptibility_to | 0.64061748 |
| 164 | MP0005671_abnormal_response_to | 0.63329527 |
| 165 | MP0002009_preneoplasia | 0.62930172 |
| 166 | MP0009643_abnormal_urine_homeostasis | 0.62529941 |
| 167 | MP0004782_abnormal_surfactant_physiolog | 0.62328075 |
| 168 | MP0002249_abnormal_larynx_morphology | 0.61638775 |
| 169 | MP0001119_abnormal_female_reproductive | 0.61381645 |
| 170 | MP0002078_abnormal_glucose_homeostasis | 0.61347383 |
| 171 | MP0002102_abnormal_ear_morphology | 0.61094074 |
| 172 | MP0001800_abnormal_humoral_immune | 0.59663083 |
| 173 | MP0001188_hyperpigmentation | 0.59597339 |
| 174 | MP0009642_abnormal_blood_homeostasis | 0.59124884 |
| 175 | MP0000598_abnormal_liver_morphology | 0.58763334 |
| 176 | MP0005645_abnormal_hypothalamus_physiol | 0.56831585 |
| 177 | MP0003943_abnormal_hepatobiliary_system | 0.56793816 |
| 178 | MP0005025_abnormal_response_to | 0.53715894 |
| 179 | MP0000371_diluted_coat_color | 0.53226157 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Prolonged partial thromboplastin time (HP:0003645) | 5.02796955 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 4.94460293 |
| 3 | Pancreatic cysts (HP:0001737) | 4.69395445 |
| 4 | Conjugated hyperbilirubinemia (HP:0002908) | 4.62726734 |
| 5 | Molar tooth sign on MRI (HP:0002419) | 4.27464306 |
| 6 | Abnormality of midbrain morphology (HP:0002418) | 4.27464306 |
| 7 | Pancreatic fibrosis (HP:0100732) | 4.27329058 |
| 8 | True hermaphroditism (HP:0010459) | 4.06996338 |
| 9 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.96379981 |
| 10 | Deep venous thrombosis (HP:0002625) | 3.93155487 |
| 11 | Joint hemorrhage (HP:0005261) | 3.90841272 |
| 12 | Congenital stationary night blindness (HP:0007642) | 3.85789574 |
| 13 | Nephronophthisis (HP:0000090) | 3.85473782 |
| 14 | Renal cortical cysts (HP:0000803) | 3.71715047 |
| 15 | Complement deficiency (HP:0004431) | 3.62382113 |
| 16 | Hyperlipoproteinemia (HP:0010980) | 3.48223660 |
| 17 | Hyperventilation (HP:0002883) | 3.37585904 |
| 18 | Epidermoid cyst (HP:0200040) | 3.35889490 |
| 19 | Abnormal biliary tract physiology (HP:0012439) | 3.35335300 |
| 20 | Bile duct proliferation (HP:0001408) | 3.35335300 |
| 21 | Abnormality of the renal medulla (HP:0100957) | 3.35240413 |
| 22 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.26183540 |
| 23 | Type II lissencephaly (HP:0007260) | 3.25529789 |
| 24 | Xanthomatosis (HP:0000991) | 3.06624560 |
| 25 | Abnormality of the fingertips (HP:0001211) | 3.03108233 |
| 26 | Medial flaring of the eyebrow (HP:0010747) | 3.01484088 |
| 27 | Hypoglycemic coma (HP:0001325) | 3.00577201 |
| 28 | Tubular atrophy (HP:0000092) | 2.91362169 |
| 29 | Chronic hepatic failure (HP:0100626) | 2.89205284 |
| 30 | Inability to walk (HP:0002540) | 2.86381417 |
| 31 | Abnormality of methionine metabolism (HP:0010901) | 2.85786200 |
| 32 | Hyperglycinuria (HP:0003108) | 2.83169326 |
| 33 | Cystic liver disease (HP:0006706) | 2.81869814 |
| 34 | Congenital, generalized hypertrichosis (HP:0004540) | 2.79608577 |
| 35 | Gingival bleeding (HP:0000225) | 2.74872464 |
| 36 | Attenuation of retinal blood vessels (HP:0007843) | 2.72186931 |
| 37 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.71304516 |
| 38 | Abnormality of alanine metabolism (HP:0010916) | 2.71304516 |
| 39 | Hyperalaninemia (HP:0003348) | 2.71304516 |
| 40 | Abnormality of the renal cortex (HP:0011035) | 2.70997204 |
| 41 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.69160139 |
| 42 | Hypercholesterolemia (HP:0003124) | 2.68977264 |
| 43 | Abnormality of the common coagulation pathway (HP:0010990) | 2.67389920 |
| 44 | Hypoglycemic seizures (HP:0002173) | 2.67356555 |
| 45 | Abnormality of the intrinsic pathway (HP:0010989) | 2.66687009 |
| 46 | Abolished electroretinogram (ERG) (HP:0000550) | 2.64817971 |
| 47 | Lip pit (HP:0100267) | 2.63107748 |
| 48 | Lissencephaly (HP:0001339) | 2.62693273 |
| 49 | Fat malabsorption (HP:0002630) | 2.62576911 |
| 50 | Ketosis (HP:0001946) | 2.60030891 |
| 51 | Large for gestational age (HP:0001520) | 2.59433274 |
| 52 | Progressive inability to walk (HP:0002505) | 2.57778574 |
| 53 | Birth length less than 3rd percentile (HP:0003561) | 2.57367085 |
| 54 | Fair hair (HP:0002286) | 2.53380316 |
| 55 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.52142914 |
| 56 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.51891183 |
| 57 | Hypoalphalipoproteinemia (HP:0003233) | 2.51589478 |
| 58 | Enlarged kidneys (HP:0000105) | 2.48566770 |
| 59 | Progressive cerebellar ataxia (HP:0002073) | 2.48332872 |
| 60 | Gait imbalance (HP:0002141) | 2.48310110 |
| 61 | Protruding tongue (HP:0010808) | 2.44856935 |
| 62 | Concave nail (HP:0001598) | 2.44722377 |
| 63 | Myocardial infarction (HP:0001658) | 2.43440480 |
| 64 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.42882649 |
| 65 | Sclerocornea (HP:0000647) | 2.42737382 |
| 66 | Hypobetalipoproteinemia (HP:0003563) | 2.39432083 |
| 67 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.38606850 |
| 68 | Abnormality of glycine metabolism (HP:0010895) | 2.38606850 |
| 69 | Polydipsia (HP:0001959) | 2.38188903 |
| 70 | Abnormal drinking behavior (HP:0030082) | 2.38188903 |
| 71 | Spontaneous abortion (HP:0005268) | 2.37257882 |
| 72 | Hyperglycinemia (HP:0002154) | 2.36370789 |
| 73 | Patellar aplasia (HP:0006443) | 2.36358307 |
| 74 | Pendular nystagmus (HP:0012043) | 2.36252466 |
| 75 | Congenital primary aphakia (HP:0007707) | 2.36152405 |
| 76 | Vascular calcification (HP:0004934) | 2.34702542 |
| 77 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.33087129 |
| 78 | Hyperbilirubinemia (HP:0002904) | 2.33020174 |
| 79 | Hypoplasia of the thymus (HP:0000778) | 2.32835789 |
| 80 | Genetic anticipation (HP:0003743) | 2.32459485 |
| 81 | Generalized aminoaciduria (HP:0002909) | 2.32150964 |
| 82 | Nephrogenic diabetes insipidus (HP:0009806) | 2.31917464 |
| 83 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.31644180 |
| 84 | Cerebellar dysplasia (HP:0007033) | 2.31070947 |
| 85 | Mitral stenosis (HP:0001718) | 2.30448945 |
| 86 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 2.29011602 |
| 87 | Symptomatic seizures (HP:0011145) | 2.27994655 |
| 88 | Furrowed tongue (HP:0000221) | 2.27346105 |
| 89 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.26217506 |
| 90 | Congenital hepatic fibrosis (HP:0002612) | 2.25643985 |
| 91 | Gaze-evoked nystagmus (HP:0000640) | 2.25477605 |
| 92 | Hyperammonemia (HP:0001987) | 2.25050708 |
| 93 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.23420228 |
| 94 | Anencephaly (HP:0002323) | 2.21788281 |
| 95 | Neonatal hypoglycemia (HP:0001998) | 2.21327229 |
| 96 | Hypolipoproteinemia (HP:0010981) | 2.21149357 |
| 97 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.20138651 |
| 98 | Chronic diarrhea (HP:0002028) | 2.19831200 |
| 99 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.17434664 |
| 100 | Absent/shortened dynein arms (HP:0200106) | 2.17434664 |
| 101 | Hypothermia (HP:0002045) | 2.16088956 |
| 102 | Pigmentary retinal degeneration (HP:0001146) | 2.16023163 |
| 103 | Broad-based gait (HP:0002136) | 2.15838013 |
| 104 | Abnormality of complement system (HP:0005339) | 2.15312580 |
| 105 | Male pseudohermaphroditism (HP:0000037) | 2.11863541 |
| 106 | Keratoconus (HP:0000563) | 2.10383001 |
| 107 | Increased corneal curvature (HP:0100692) | 2.10383001 |
| 108 | Abnormality of incisor morphology (HP:0011063) | 2.08135197 |
| 109 | Decreased central vision (HP:0007663) | 2.07788077 |
| 110 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.06953595 |
| 111 | Dicarboxylic aciduria (HP:0003215) | 2.06953595 |
| 112 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.06687182 |
| 113 | Depressed nasal tip (HP:0000437) | 2.05960030 |
| 114 | Chorioretinal atrophy (HP:0000533) | 2.05468553 |
| 115 | Abnormality of the pons (HP:0007361) | 2.05342635 |
| 116 | Elevated hepatic transaminases (HP:0002910) | 2.05272809 |
| 117 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.05209651 |
| 118 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.05209651 |
| 119 | Cardiovascular calcification (HP:0011915) | 2.05140745 |
| 120 | Decreased circulating renin level (HP:0003351) | 2.04826898 |
| 121 | Genital tract atresia (HP:0001827) | 2.02859552 |
| 122 | Ectropion (HP:0000656) | 2.01112823 |
| 123 | Bilateral microphthalmos (HP:0007633) | 2.00664415 |
| 124 | Portal hypertension (HP:0001409) | 2.00277223 |
| 125 | Clumsiness (HP:0002312) | 1.99971012 |
| 126 | Retinal dysplasia (HP:0007973) | 1.98927157 |
| 127 | Abnormality of the hepatic vasculature (HP:0006707) | 1.98482776 |
| 128 | Abnormal ciliary motility (HP:0012262) | 1.97536043 |
| 129 | Vaginal atresia (HP:0000148) | 1.97268122 |
| 130 | Osteomalacia (HP:0002749) | 1.96099481 |
| 131 | Polyuria (HP:0000103) | 1.93039770 |
| 132 | Abnormality of the columella (HP:0009929) | 1.92528609 |
| 133 | Generalized hypopigmentation of hair (HP:0011358) | 1.92402723 |
| 134 | Colon cancer (HP:0003003) | 1.92200451 |
| 135 | Steatorrhea (HP:0002570) | 1.91510804 |
| 136 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.91226606 |
| 137 | Hemorrhage of the eye (HP:0011885) | 1.90353238 |
| 138 | Hemiparesis (HP:0001269) | 1.89958500 |
| 139 | Hypoplasia of the pons (HP:0012110) | 1.89423293 |
| 140 | Glomerulonephritis (HP:0000099) | 1.88684481 |
| 141 | Postaxial foot polydactyly (HP:0001830) | 1.88174919 |
| 142 | Febrile seizures (HP:0002373) | 1.88170579 |
| 143 | Pachygyria (HP:0001302) | 1.86573914 |
| 144 | Increased CSF lactate (HP:0002490) | 1.85149657 |
| 145 | Mitochondrial inheritance (HP:0001427) | 1.83738346 |
| 146 | Delayed CNS myelination (HP:0002188) | 1.83660972 |
| 147 | Poor coordination (HP:0002370) | 1.83216096 |
| 148 | Metabolic acidosis (HP:0001942) | 1.82953445 |
| 149 | Acanthocytosis (HP:0001927) | 1.82614947 |
| 150 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.82149292 |
| 151 | Severe muscular hypotonia (HP:0006829) | 1.82137155 |
| 152 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.81255037 |
| 153 | Hypoplasia of the fovea (HP:0007750) | 1.81255037 |
| 154 | Cupped ear (HP:0000378) | 1.80306988 |
| 155 | Acute necrotizing encephalopathy (HP:0006965) | 1.80249842 |
| 156 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.80240719 |
| 157 | Abnormality of serum amino acid levels (HP:0003112) | 1.79817099 |
| 158 | Hypophosphatemic rickets (HP:0004912) | 1.79812341 |
| 159 | Methylmalonic acidemia (HP:0002912) | 1.79370332 |
| 160 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.78416863 |
| 161 | Midline defect of the nose (HP:0004122) | 1.78177266 |
| 162 | Hypochromic microcytic anemia (HP:0004840) | 1.77763074 |
| 163 | Intestinal atresia (HP:0011100) | 1.77761646 |
| 164 | 3-Methylglutaconic aciduria (HP:0003535) | 1.77087453 |
| 165 | Ketoacidosis (HP:0001993) | 1.77061398 |
| 166 | Thrombophlebitis (HP:0004418) | 1.76966712 |
| 167 | Tubulointerstitial nephritis (HP:0001970) | 1.76847972 |
| 168 | Dandy-Walker malformation (HP:0001305) | 1.75774956 |
| 169 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.75379561 |
| 170 | Occipital encephalocele (HP:0002085) | 1.74621997 |
| 171 | Hepatocellular carcinoma (HP:0001402) | 1.74027975 |
| 172 | Systemic lupus erythematosus (HP:0002725) | 1.73890944 |
| 173 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.73760629 |
| 174 | Esophageal varix (HP:0002040) | 1.72626814 |
| 175 | Acute encephalopathy (HP:0006846) | 1.72186449 |
| 176 | Hyperglycemia (HP:0003074) | 1.71231902 |
| 177 | Tachypnea (HP:0002789) | 1.71080340 |
| 178 | Focal motor seizures (HP:0011153) | 1.70717031 |
| 179 | Optic nerve hypoplasia (HP:0000609) | 1.70598882 |
| 180 | Thyroid-stimulating hormone excess (HP:0002925) | 1.67986410 |
| 181 | Epistaxis (HP:0000421) | 1.67441392 |
| 182 | Acute myeloid leukemia (HP:0004808) | 1.66604844 |
| 183 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.65583277 |
| 184 | Alveolar cell carcinoma (HP:0006519) | 1.65153396 |
| 185 | Abnormality of nucleobase metabolism (HP:0010932) | 1.64982143 |
| 186 | Renal tubular acidosis (HP:0001947) | 1.64423127 |
| 187 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.63220068 |
| 188 | Blue irides (HP:0000635) | 1.62825426 |
| 189 | Agammaglobulinemia (HP:0004432) | 1.62445192 |
| 190 | Abnormality of the axillary hair (HP:0100134) | 1.62415065 |
| 191 | Abnormality of secondary sexual hair (HP:0009888) | 1.62415065 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TNIK | 4.02157051 |
| 2 | LATS1 | 3.69717691 |
| 3 | INSRR | 3.23889563 |
| 4 | ACVR1B | 2.81299032 |
| 5 | NUAK1 | 2.64075396 |
| 6 | WNK3 | 2.48011870 |
| 7 | WNK4 | 2.39452630 |
| 8 | MKNK2 | 2.37385438 |
| 9 | TAOK3 | 2.32852030 |
| 10 | MAP4K2 | 2.26438626 |
| 11 | MAP3K4 | 2.15263058 |
| 12 | TLK1 | 2.13581719 |
| 13 | PNCK | 2.10046488 |
| 14 | SIK1 | 1.91747686 |
| 15 | MAP3K14 | 1.87007073 |
| 16 | PINK1 | 1.86742464 |
| 17 | IRAK3 | 1.84088388 |
| 18 | CAMK1D | 1.78603544 |
| 19 | MAP3K6 | 1.70280857 |
| 20 | BRD4 | 1.64940199 |
| 21 | IRAK4 | 1.63630573 |
| 22 | PRKAA2 | 1.62940720 |
| 23 | OXSR1 | 1.62589903 |
| 24 | CAMK1G | 1.62034902 |
| 25 | STK38L | 1.60094175 |
| 26 | STK39 | 1.57370711 |
| 27 | YES1 | 1.57094773 |
| 28 | SGK2 | 1.53888879 |
| 29 | MARK1 | 1.52645181 |
| 30 | MKNK1 | 1.49525945 |
| 31 | MUSK | 1.48433233 |
| 32 | EIF2AK2 | 1.46304768 |
| 33 | IKBKE | 1.46138449 |
| 34 | TGFBR1 | 1.45368379 |
| 35 | ZAK | 1.43699454 |
| 36 | ERBB4 | 1.40173108 |
| 37 | NTRK3 | 1.34566222 |
| 38 | CAMKK2 | 1.34559489 |
| 39 | DAPK2 | 1.28276771 |
| 40 | TRIM28 | 1.27902248 |
| 41 | MAP3K13 | 1.27286617 |
| 42 | DYRK2 | 1.26952791 |
| 43 | CDK3 | 1.25882176 |
| 44 | TEC | 1.24232451 |
| 45 | TGFBR2 | 1.22600646 |
| 46 | ADRBK1 | 1.19934918 |
| 47 | PIK3CG | 1.18212060 |
| 48 | CASK | 1.17756866 |
| 49 | JAK3 | 1.17626540 |
| 50 | TIE1 | 1.14327773 |
| 51 | PIK3CA | 1.13372892 |
| 52 | PAK3 | 1.10007583 |
| 53 | TYK2 | 1.09813632 |
| 54 | JAK1 | 1.08399084 |
| 55 | VRK1 | 1.07804704 |
| 56 | KIT | 1.04658725 |
| 57 | MAP2K6 | 1.04355083 |
| 58 | NLK | 1.04197469 |
| 59 | BMPR1B | 1.03884148 |
| 60 | TXK | 1.03482373 |
| 61 | MAPK11 | 1.02651700 |
| 62 | WEE1 | 1.00796584 |
| 63 | SRPK1 | 1.00104904 |
| 64 | PRKCG | 0.98535958 |
| 65 | CDK9 | 0.98364872 |
| 66 | MAPK13 | 0.95020768 |
| 67 | PKN1 | 0.93636384 |
| 68 | MAP2K7 | 0.93355115 |
| 69 | SGK3 | 0.93007244 |
| 70 | BRSK2 | 0.92945202 |
| 71 | TRPM7 | 0.92464258 |
| 72 | BTK | 0.91926048 |
| 73 | TAF1 | 0.91602027 |
| 74 | FGFR4 | 0.90416520 |
| 75 | SGK494 | 0.90332361 |
| 76 | SGK223 | 0.90332361 |
| 77 | STK3 | 0.87010401 |
| 78 | BCKDK | 0.86741718 |
| 79 | MAP3K7 | 0.86156244 |
| 80 | CLK1 | 0.85948422 |
| 81 | GRK1 | 0.85417820 |
| 82 | MAPKAPK5 | 0.84702533 |
| 83 | OBSCN | 0.83944420 |
| 84 | IKBKB | 0.83689298 |
| 85 | PRKCE | 0.83129344 |
| 86 | CHUK | 0.82869174 |
| 87 | ERN1 | 0.82695849 |
| 88 | MAP2K3 | 0.81037419 |
| 89 | MAPKAPK3 | 0.80844967 |
| 90 | MAPK7 | 0.80266150 |
| 91 | FGFR2 | 0.80133975 |
| 92 | NEK6 | 0.72869852 |
| 93 | CSNK1G2 | 0.72332308 |
| 94 | PRKAA1 | 0.71673309 |
| 95 | CSNK1G1 | 0.71399652 |
| 96 | PLK2 | 0.71347856 |
| 97 | TSSK6 | 0.70122380 |
| 98 | BCR | 0.68444114 |
| 99 | NME1 | 0.67590790 |
| 100 | PHKG1 | 0.67356562 |
| 101 | PHKG2 | 0.67356562 |
| 102 | MAPK12 | 0.65687033 |
| 103 | PLK3 | 0.65537159 |
| 104 | ITK | 0.65327155 |
| 105 | FLT3 | 0.64451647 |
| 106 | VRK2 | 0.64107567 |
| 107 | STK4 | 0.60771325 |
| 108 | ABL1 | 0.60737480 |
| 109 | PTK2B | 0.59064422 |
| 110 | CSNK1G3 | 0.58538437 |
| 111 | NTRK2 | 0.58531019 |
| 112 | STK16 | 0.57879993 |
| 113 | CSNK1A1L | 0.57116514 |
| 114 | ERBB2 | 0.56977099 |
| 115 | SGK1 | 0.56672476 |
| 116 | MAP2K4 | 0.56367499 |
| 117 | MAPK15 | 0.55663552 |
| 118 | PLK4 | 0.54645467 |
| 119 | FRK | 0.54327652 |
| 120 | FGFR3 | 0.53891682 |
| 121 | CAMK4 | 0.53715430 |
| 122 | STK11 | 0.53704757 |
| 123 | TBK1 | 0.53329457 |
| 124 | PRKCQ | 0.52978005 |
| 125 | EPHA3 | 0.51586106 |
| 126 | CAMK2A | 0.51397319 |
| 127 | SIK3 | 0.51335784 |
| 128 | NEK9 | 0.51051233 |
| 129 | NEK2 | 0.49911738 |
| 130 | ADRBK2 | 0.49678326 |
| 131 | RPS6KA5 | 0.49184106 |
| 132 | IGF1R | 0.48346386 |
| 133 | ERBB3 | 0.47847585 |
| 134 | CDK6 | 0.47440255 |
| 135 | CAMK1 | 0.45148671 |
| 136 | CSF1R | 0.44971794 |
| 137 | DMPK | 0.44605680 |
| 138 | LYN | 0.44536317 |
| 139 | CDK19 | 0.43745359 |
| 140 | IRAK2 | 0.43404795 |
| 141 | SIK2 | 0.43127614 |
| 142 | PTK6 | 0.42664899 |
| 143 | HCK | 0.41381493 |
| 144 | JAK2 | 0.41150385 |
| 145 | PRKACA | 0.40626827 |
| 146 | CDK8 | 0.40129760 |
| 147 | DYRK1A | 0.39526023 |
| 148 | PASK | 0.38314692 |
| 149 | TYRO3 | 0.38011227 |
| 150 | PRKG1 | 0.37181444 |
| 151 | CSNK1A1 | 0.36942089 |
| 152 | CHEK2 | 0.36933887 |
| 153 | EPHA4 | 0.34855396 |
| 154 | IRAK1 | 0.32973181 |
| 155 | PLK1 | 0.32707871 |
| 156 | MAP2K1 | 0.31626187 |
| 157 | DYRK3 | 0.31518758 |
| 158 | CSNK1D | 0.31124055 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.92165378 |
| 2 | Phototransduction_Homo sapiens_hsa04744 | 2.83101640 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.71786560 |
| 4 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.67874187 |
| 5 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.62032028 |
| 6 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.61311110 |
| 7 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.45305941 |
| 8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.44046822 |
| 9 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.33212330 |
| 10 | Nicotine addiction_Homo sapiens_hsa05033 | 2.26010172 |
| 11 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.23681485 |
| 12 | Peroxisome_Homo sapiens_hsa04146 | 2.22828199 |
| 13 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.20383527 |
| 14 | Lysine degradation_Homo sapiens_hsa00310 | 2.11001828 |
| 15 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.10657397 |
| 16 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 2.06255771 |
| 17 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.03685643 |
| 18 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.02678083 |
| 19 | ABC transporters_Homo sapiens_hsa02010 | 1.98501160 |
| 20 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.96542759 |
| 21 | Retinol metabolism_Homo sapiens_hsa00830 | 1.88202699 |
| 22 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.87131528 |
| 23 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.86780054 |
| 24 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.86439027 |
| 25 | Homologous recombination_Homo sapiens_hsa03440 | 1.85758925 |
| 26 | Histidine metabolism_Homo sapiens_hsa00340 | 1.84762278 |
| 27 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.82141702 |
| 28 | Protein export_Homo sapiens_hsa03060 | 1.76205377 |
| 29 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.74002379 |
| 30 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.73498871 |
| 31 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.73184559 |
| 32 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.73113733 |
| 33 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.70073977 |
| 34 | Parkinsons disease_Homo sapiens_hsa05012 | 1.67037882 |
| 35 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.66394307 |
| 36 | RNA polymerase_Homo sapiens_hsa03020 | 1.62666413 |
| 37 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.59337547 |
| 38 | Basal transcription factors_Homo sapiens_hsa03022 | 1.57219111 |
| 39 | Olfactory transduction_Homo sapiens_hsa04740 | 1.53746815 |
| 40 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.53452405 |
| 41 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.49610803 |
| 42 | Taste transduction_Homo sapiens_hsa04742 | 1.42690058 |
| 43 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.38937962 |
| 44 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.36669285 |
| 45 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.34686505 |
| 46 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.33483682 |
| 47 | Morphine addiction_Homo sapiens_hsa05032 | 1.31838868 |
| 48 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.22659466 |
| 49 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.22628870 |
| 50 | Huntingtons disease_Homo sapiens_hsa05016 | 1.19869818 |
| 51 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.18839802 |
| 52 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.18523925 |
| 53 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.16980838 |
| 54 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.15651397 |
| 55 | Alzheimers disease_Homo sapiens_hsa05010 | 1.12502122 |
| 56 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.09869479 |
| 57 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.08720045 |
| 58 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.07835306 |
| 59 | RNA degradation_Homo sapiens_hsa03018 | 1.05324644 |
| 60 | Circadian entrainment_Homo sapiens_hsa04713 | 1.05214958 |
| 61 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.05171295 |
| 62 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.03224373 |
| 63 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.03066645 |
| 64 | GABAergic synapse_Homo sapiens_hsa04727 | 1.01781715 |
| 65 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.00826035 |
| 66 | Bile secretion_Homo sapiens_hsa04976 | 0.99447041 |
| 67 | Insulin secretion_Homo sapiens_hsa04911 | 0.98664027 |
| 68 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.98506436 |
| 69 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.96964478 |
| 70 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.94907927 |
| 71 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.92345375 |
| 72 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.91479605 |
| 73 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.90970673 |
| 74 | Circadian rhythm_Homo sapiens_hsa04710 | 0.90233105 |
| 75 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.88600498 |
| 76 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.88451222 |
| 77 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.82474112 |
| 78 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.81234443 |
| 79 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.77890659 |
| 80 | Cocaine addiction_Homo sapiens_hsa05030 | 0.75250619 |
| 81 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.74744549 |
| 82 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.73173309 |
| 83 | Purine metabolism_Homo sapiens_hsa00230 | 0.72254623 |
| 84 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.71070071 |
| 85 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.70861052 |
| 86 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.67991568 |
| 87 | Salivary secretion_Homo sapiens_hsa04970 | 0.65532525 |
| 88 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.64468675 |
| 89 | Sulfur relay system_Homo sapiens_hsa04122 | 0.64142007 |
| 90 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.63702625 |
| 91 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.63204226 |
| 92 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.62775551 |
| 93 | Insulin resistance_Homo sapiens_hsa04931 | 0.62480289 |
| 94 | Ribosome_Homo sapiens_hsa03010 | 0.58008072 |
| 95 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.56083735 |
| 96 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.56001698 |
| 97 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.55194047 |
| 98 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.55060903 |
| 99 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.54523389 |
| 100 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.53695541 |
| 101 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.52743860 |
| 102 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.51873935 |
| 103 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.50298131 |
| 104 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.49953228 |
| 105 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.49472819 |
| 106 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.49229090 |
| 107 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.48899289 |
| 108 | Long-term depression_Homo sapiens_hsa04730 | 0.48632899 |
| 109 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.48619319 |
| 110 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.48491262 |
| 111 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.47286838 |
| 112 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.46775658 |
| 113 | Measles_Homo sapiens_hsa05162 | 0.45040281 |
| 114 | Other glycan degradation_Homo sapiens_hsa00511 | 0.42933576 |
| 115 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.41447206 |
| 116 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.40779054 |
| 117 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.40715615 |
| 118 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.40395735 |
| 119 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.40165211 |
| 120 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.38944996 |
| 121 | Asthma_Homo sapiens_hsa05310 | 0.38398075 |
| 122 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.38394018 |
| 123 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.35349455 |
| 124 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.35292498 |
| 125 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.34444158 |
| 126 | Mineral absorption_Homo sapiens_hsa04978 | 0.34392087 |
| 127 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.34265030 |
| 128 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.34237898 |
| 129 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.33923949 |
| 130 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.31748701 |
| 131 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.30548182 |
| 132 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.30288298 |
| 133 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.28846923 |
| 134 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.26953543 |
| 135 | Hepatitis C_Homo sapiens_hsa05160 | 0.26846714 |
| 136 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.26683028 |
| 137 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.25816847 |
| 138 | Influenza A_Homo sapiens_hsa05164 | 0.25760308 |
| 139 | Metabolic pathways_Homo sapiens_hsa01100 | 0.25558907 |
| 140 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.24403581 |
| 141 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.22444951 |
| 142 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.21917416 |
| 143 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.20670512 |
| 144 | Leishmaniasis_Homo sapiens_hsa05140 | 0.19174876 |
| 145 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.19132693 |
| 146 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.18405180 |
| 147 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.16281860 |
| 148 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.16118362 |
| 149 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.15327083 |
| 150 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.13112159 |
| 151 | Malaria_Homo sapiens_hsa05144 | 0.13037455 |

